Suomen Terveystalo Oy

At Suomen Terveystalo Oy in Helsinki, clinical trials in mental health focus on major depressive disorder, generalized anxiety disorder, and related symptoms such as anhedonia. The studies are designed to test new treatment options and assess whether they can improve mood, anxiety, and daily functioning in people who have not responded well to current care.

• Research on adjunctive and stand-alone approaches for major depressive disorder
• Studies targeting generalized anxiety disorder and persistent anxiety symptoms
• Trials evaluating whether new therapies can improve depressive symptoms and overall well-being

These trials reflect a strong interest in finding better options for common and often hard-to-treat psychiatric conditions.

The site also conducts research in neurology, with studies involving migraine, narcolepsy, and mild to moderate Alzheimer’s disease. The main goals include preventing migraine attacks, reducing daytime sleepiness, and improving thinking skills and global function in people with cognitive decline.

• Trials for migraine prevention and acute relief in adults and children
• Studies in narcolepsy and narcolepsy with cataplexy aimed at managing excessive sleepiness
• Research in Alzheimer’s disease focused on cognition and daily functioning

These investigations support the development of more effective therapies for neurological disorders that can significantly affect quality of life.

Clinical trial activity in cardiovascular diseases includes work on heart failure, hypertension, and broader cardiovascular disease risk in people with metabolic conditions. The research is aimed at improving outcomes, lowering the risk of serious heart events, and testing new treatment combinations for patients with complex disease profiles.

• Studies in heart failure with preserved or mildly reduced ejection fraction and obesity
• Trials in type 2 diabetes, hypertension, and established cardiovascular disease
• Research evaluating whether new therapies can reduce hospitalizations and cardiovascular deaths

These trials highlight a focus on better long-term care for patients with overlapping heart and metabolic conditions.

In the area of respiratory tract diseases, the site is involved in studies on chronic obstructive pulmonary disease and related cardiopulmonary outcomes. The purpose of this research is to determine whether new treatment combinations can improve breathing-related health and reduce serious complications.

• Trials in COPD examining symptom control and overall respiratory outcomes
• Research linking lung disease treatment with broader cardiopulmonary benefits
• Studies designed to evaluate the effectiveness of new inhaled and combined therapies

This work supports efforts to improve both daily respiratory symptoms and longer-term disease control.

Research in digestive system diseases centers on celiac disease, with trials exploring ways to reduce gluten-related intestinal injury and improve disease management. The main objective is to test new therapies that may protect the gut and offer better control of symptoms and inflammation.

• Studies in celiac disease focused on reducing gluten-induced intestinal damage
• Research aimed at improving treatment options for people living with ongoing dietary sensitivity
• Clinical testing of approaches intended to support safer and more effective disease control

This area adds an important digestive health dimension to the broader clinical research portfolio at the site.